Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2017 - 2026)
Ovid Therapeutics (OVID) reported Net Equity Issued and Repurchased of -$3.62 million for Q2 2026.
Powered by 
Analysis
Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ovid Therapeutics' Net Equity Issued and Repurchased came in at $131.29 million; for FY2025, it came in at $75.12 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $622,000 in FY2024 (+16.3%), $535,000 in FY2023 (+196.1%), $180,658 in FY2022 (-80.5%) and $925,396 in FY2021 (-98.0%).
- The Q2 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q3 2019.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q2 2022 (growth of 414.7%); the low point was Q4 2021 (a decline of 99.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $59.8 million (Q1 2026), $75.09 million (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Ovid Therapeutics | 448.96 Mn | 80.98 Mn | - | -3.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.62 Mn |
| Mar 31, 2026 | 59.80 Mn |
| Dec 31, 2025 | 75.09 Mn |
| Sep 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 356,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 224,000.00 |
| Jun 30, 2023 | 211,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | -43,599.00 |
| Sep 30, 2022 | 81,629.00 |
| Jun 30, 2022 | 109,549.00 |
| Mar 31, 2022 | 33,079.00 |
| Dec 31, 2021 | 313,858.00 |
| Sep 30, 2021 | 460,080.00 |
| Jun 30, 2021 | 21,285.00 |
| Mar 31, 2021 | 130,173.00 |
API Access
Ovid Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();